Detalhe da pesquisa
1.
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.
Ann Oncol
; 35(3): 248-266, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38307807
2.
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.
Ann Oncol
; 33(11): 1119-1133, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35963481
3.
The systemic treatment of recurrent ovarian cancer revisited.
Ann Oncol
; 32(6): 710-725, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33675937
4.
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.
Gynecol Oncol
; 163(3): 598-604, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34649724
5.
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS).
Gynecol Oncol
; 156(1): 45-53, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31836184
6.
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Gynecol Oncol
; 158(3): 666-672, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32624235
7.
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
Gynecol Oncol
; 157(1): 78-84, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32131977
8.
Impact on mental health of the COVID-19 outbreak among community pharmacists during the sanitary lockdown period.
Ann Pharm Fr
; 78(6): 459-463, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33038309
9.
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Ann Oncol
; 30(12): 1925-1940, 2019 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31617564
10.
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ann Oncol
; 30(11): 1784-1795, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31591636
11.
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Ann Oncol
; 30(5): 845-852, 2019 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30851097
12.
Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence.
Support Care Cancer
; 27(9): 3573-3581, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-30690685
13.
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries.
Ann Oncol
; 29(4): 910-916, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29415128
14.
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.
Ann Oncol
; 29(8): 1658-1686, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30113631
15.
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
Br J Cancer
; 116(3): 303-309, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28072765
16.
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 33(9): 860-877, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35690222
17.
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.
Ann Oncol
; 28(4): 727-732, 2017 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27993805
18.
Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study.
Br J Cancer
; 115(1): 20-4, 2016 Jun 28.
Artigo
Inglês
| MEDLINE | ID: mdl-27253171
19.
Statistical controversies in clinical research: should schedules of tumor size assessments be changed?
Ann Oncol
; 27(11): 1981-1987, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27502711
20.
Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy.
Ann Oncol
; 26(1): 231-237, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25355720